These results fit a scenario where granzyme B degraded type IV collagen fragments (C4G) are released to the circulation when cytotoxic T cells release granzyme B to break down type IV collagen to pass through basement membranes on the route from the blood into the tumor tissue [14]. The gene discussed is GZMB; the disease is neoplasm.